You are here
Clinical Trials: Digestive System Disease
Each Clinical Trial will open in a new browser window or tab.
Condition: Complex Perianal Fistulas
Interventions: Biological: Human TH-SC01 Cell Injection; Other: Saline solution
Sponsors: Jiangsu Topcel-KH Pharmaceutical Co., Ltd.; Xiangya Hospital of Central South University
Not yet recruiting
Interventions: Biological: Human TH-SC01 Cell Injection; Other: Saline solution
Sponsors: Jiangsu Topcel-KH Pharmaceutical Co., Ltd.; Xiangya Hospital of Central South University
Not yet recruiting
Conditions: Autism Spectrum Disorder; Gastrointestinal Dysfunction; Leaky Gut Syndrome; Mesenchymal Stromal Cells; Inflammatory Bowel Diseases
Intervention: Drug: Adipose tissue derived mesenchymal stromal/stem cells (Cell2Cure®)
Sponsor: Cell2Cure ApS
Not yet recruiting
Intervention: Drug: Adipose tissue derived mesenchymal stromal/stem cells (Cell2Cure®)
Sponsor: Cell2Cure ApS
Not yet recruiting
Condition: Ischemic Bowel Disease
Intervention: Other: Human Umbilical Cord blood mononuclear cells
Sponsor: Qianfoshan Hospital
Recruiting
Intervention: Other: Human Umbilical Cord blood mononuclear cells
Sponsor: Qianfoshan Hospital
Recruiting
Conditions: Stenosis; Bowel; Crohn Disease
Intervention: Drug: Adipose derived allogenic mesenchymal stem cells (adAMSC)
Sponsors: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz; Effice Servicios Para la Investigacion S.L.
Not yet recruiting
Intervention: Drug: Adipose derived allogenic mesenchymal stem cells (adAMSC)
Sponsors: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz; Effice Servicios Para la Investigacion S.L.
Not yet recruiting
Condition: Cirrhosis Due to Hepatitis B
Interventions: Biological: UC-MSCs; Biological: Saline solution
Sponsors: Renmin Hospital of Wuhan University; VCANBIO Cell & Gene Engineering Corporation, Ltd; Wuhan Optics Valley Zhongyuan Pharmaceutical Co., Ltd., Hubei, China
Recruiting
Interventions: Biological: UC-MSCs; Biological: Saline solution
Sponsors: Renmin Hospital of Wuhan University; VCANBIO Cell & Gene Engineering Corporation, Ltd; Wuhan Optics Valley Zhongyuan Pharmaceutical Co., Ltd., Hubei, China
Recruiting
Condition: Acute Liver Failure
Intervention: Biological: HMB002
Sponsors: King's College Hospital NHS Trust; Medical Research Council
Not yet recruiting
Intervention: Biological: HMB002
Sponsors: King's College Hospital NHS Trust; Medical Research Council
Not yet recruiting
Condition: Rectal Fistula
Interventions: Biological: OSSM-001; Other: Placebo
Sponsor: Ossium Health, Inc.
Not yet recruiting
Interventions: Biological: OSSM-001; Other: Placebo
Sponsor: Ossium Health, Inc.
Not yet recruiting
Condition: Fistula Perianal
Intervention: Other: placenta-MSCs derived exosomes
Sponsor: Tehran University of Medical Sciences
Recruiting
Intervention: Other: placenta-MSCs derived exosomes
Sponsor: Tehran University of Medical Sciences
Recruiting
Conditions: Digestive System Diseases; Inflammatory Bowel Disease, Ulcerative Colitis Type; Crohn Disease
Intervention: Procedure: additional biopsies
Sponsor: Rennes University Hospital
Not yet recruiting
Intervention: Procedure: additional biopsies
Sponsor: Rennes University Hospital
Not yet recruiting
Condition: Crohn Disease
Intervention: Biological: Human Umbilical Cord Mesenchymal Stem Cells
Sponsor: Shanghai East Hospital
Not yet recruiting
Intervention: Biological: Human Umbilical Cord Mesenchymal Stem Cells
Sponsor: Shanghai East Hospital
Not yet recruiting